NeuroPace Strengthens Leadership with New Appointment
NeuroPace, Inc. (Nasdaq: NPCE), based in Mountain View, California, is a forward-thinking medical device company committed to changing the lives of individuals living with epilepsy, recently took a significant step in enhancing its leadership team. The company announced the appointment of Amy Treadwell as the new Vice President of Human Resources, effective immediately.
Emphasizing Engagement and Growth
The excitement surrounding Amy's appointment is palpable. Joel Becker, the Chief Executive Officer of NeuroPace, expressed enthusiasm about Treadwell’s addition to the team, stating that her expertise will be instrumental in fostering a high-performing, engaged culture essential for the company's ongoing growth. With numerous substantial opportunities on the horizon, NeuroPace is at a pivotal moment in its journey. Becker believes Treadwell's role, alongside Brett Wingeier as Vice President of Research and Development and Katie Keller taking the helm as Vice President of Marketing, will solidify their position to fully leverage these opportunities.
A Commitment to People Development
In her own words, Treadwell conveyed her eagerness to join the NeuroPace team, underscoring her commitment to developing talent within the organization to seize the promising opportunities ahead. Her enthusiasm signals a renewed focus on nurturing the company’s most valuable asset—its people.
Expertise in Healthcare and Technology
Amy Treadwell brings a wealth of experience to NeuroPace, having cultivated a successful career in both healthcare and technology sectors. Most recently, she held the position of Vice President of People at CyCognito, a cybersecurity startup. Prior to that, her career included significant human resources leadership roles at Carbon Health, Fitbit, and eBay.
Educational Background
Treadwell's academic credentials further bolster her qualifications. She holds a Juris Doctor degree from the Santa Clara University School of Law and a Bachelor of Arts degree in International Relations from the University of Southern California. This mix of extensive industry experience and solid educational background positions her well to lead the human resources function at NeuroPace.
About NeuroPace, Inc.
NeuroPace is dedicated to revolutionizing the treatment of epilepsy through its innovative RNS System, which provides personalized, real-time interventions at the source of seizures. This technology not only aims to reduce the frequency of debilitating seizures but also aspires to enhance the standard of care for patients facing drug-resistant epilepsy. Moreover, it opens up possibilities for improved outcomes for a broader range of brain disorders.
Innovative Solutions for Patients
With the RNS System, NeuroPace is pioneering a new approach in the field of neurology. This cutting-edge platform is the first commercially available brain-responsive device of its kind, representing a significant advancement in the treatment of epilepsy.
Frequently Asked Questions
What recent leadership changes has NeuroPace made?
NeuroPace recently appointed Amy Treadwell as Vice President of Human Resources, along with other leadership updates to support its growth strategy.
What is the significance of Amy Treadwell's appointment?
Treadwell's appointment is expected to enhance employee engagement and support NeuroPace in capitalizing on significant growth opportunities.
What does NeuroPace focus on in its operations?
The company is dedicated to improving the lives of individuals with epilepsy through its innovative RNS technology, which provides personalized seizure intervention.
How does the RNS System work?
The RNS System detects abnormal brain activity and delivers tailored electrical stimulation to prevent seizures, representing a groundbreaking approach in epilepsy care.
Who can benefit from NeuroPace's solutions?
Patients with drug-resistant epilepsy and potential others facing brain disorders can benefit from the personalized treatment options offered by NeuroPace's RNS System.
